Interleukin-13 -1112 C/T Promoter Polymorphism Confers Risk for COPD: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Chen, Lei ^a   Shen, Yongchun ^a   Liu, Lian ^a   Li, Xiaoou ^a   Wang, Tao ^a   Wen, Fuqiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; INTERLEUKIN 13; THYMINE;

AMINO ACID SUBSTITUTION; ARTICLE; ASIA; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFIDENCE INTERVAL; DATA BASE; DATA EXTRACTION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EFFECT SIZE; ETHNICITY; GENETIC MODEL; GENOTYPE; HUMAN; MEDLINE; META ANALYSIS (TOPIC); PROMOTER REGION; RISK ASSESSMENT;

ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-13; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK;

EID: 84879964829     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068222     Document Type: Article

References (17)

1. Brightling CE, Saha S, Hollins F, (2010) Interleukin- 13: prospects for new treatments. Clin Exp Allergy 40(1): 42-9.
2. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, et al. (2000) Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 106(9): 1081-93.
3. Lee JS, Rosengart MR, Kondragunta V, Zhang Y, McMurray J, et al. (2007) Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res 8: 64.
4. Miotto D, Ruggieri MP, Boschetto P, Cavallesco G, Papi A, et al. (2003) Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis. Eur Respir J 22: 602-608.
5. Artigas MS, Wain LV, Tobin MD, (2012) Genome-wide association studies in lung disease. Thorax 67: 271-273.
6. Todd JL, Goldstein DB, Ge D, Christie J, Palmer SM, (2011) The State of Genome-Wide Association Studies in Pulmonary Disease: A New Perspective. Am J Respir Crit Care Med 184: 873-880.
7. Haq I, Chappell S, Johnson SR, Lotya J, Daly L, et al. (2010) Association of MMP-12 polymorphisms with severe and very severe COPD: A case control study of MMPs-1, 9 and 12 in an European population. BMC Medical Genetics 11: 7.
8. van der Pouw Kraan TC, Kucukaycan M, Bakker AM, Baggen JM, van der Zee JS, et al. (2002) Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes Immun 3(7): 436-9.
9. Sadeghnejad A, Meyers DA, Bottai M, Sterling DA, Bleecker ER, et al. (2007) IL13 Promoter Polymorphism -1112C/T Modulates the Adverse Effect of Tobacco Smoking on Lung Function. Am J Respir Crit Care Med 176: 748-752.
10. Hegab AE, Sakamoto T, Saitoh W, Massoud HH, Massoud HM, et al. (2004) Polymorphisms of IL4, IL13, and ADRB2 genes in COPD. Chest 126(6): 1832-9.
11. Jiang L, He B, Zhao MW, L Ning D, Li XY, et al. (2005) Association of gene polymorphisms of tumour necrosis factor-alpha and interleukin-13 with chronic obstructive pulmonary disease in Han nationality in Beijing. Chin Med J (Engl) 118(7): 541-7.
12. Liu SF, Chen YC, Wang CC, Fang WF, Chin CH, et al. (2009) IL13 promoter (-1055) polymorphisms associated with chronic obstructive pulmonary disease in Taiwanese. Exp Lung Res 35(10): 807-16.
13. Beghe B, Hall IP, Parker SG, Moffatt MF, Wardlaw A, et al. (2010) Polymorphisms in IL13 pathway genes in asthma and chronicobstructive pulmonary disease. Allergy 65(4): 474-81.
14. Dong SJ, Tuohayi J, Hu XT, Zhao SS, (2010) Correlation between polymorphism of interleukin-13 gene and susceptibility to chronic obstructive pulmonary disease in Uygur nationality in Xinj iang. Zhong Hua Shi Yong Zhen Duan Yu Zhi Liao Za Zhi 24(10): 984-986.
15. Ezzeldin N, Shalaby A, Saad-Hussein A, Ezzeldin H, El Lebedy D, et al. (2012) Association of TNF-alpha-308G/A, SP-B 1580 C/T, IL-13 -1055 C/T genepolymorphisms and latent adenoviral infection with chronic obstructive pulmonary disease in an Egyptian population. Arch Med Sci 8(2): 286-95.
16. He JQ, Connett JE, Anthonisen NR, Sandford AJ, (2003) Polymorphisms in the IL13, IL13RA1, and IL4RA Genes and Rate of Decline in Lung Function in Smokers. Am J Respir Cell Mol Biol 28: 379.
17. Xue HP, Ni PH, Lin B, Xu H, Huang G, (2011) X-Ray Repair Cross- Complementing Group 1 (XRCC1) Genetic Polymorphisms and Gastric Cancer Risk: A HuGE Review and Meta-Analysis. Am J Epidemiol 173: 363-375.